Your account is not claimed yet. You can sign up with ORCID to claim your account.

Hans Garmo

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Acta oncologica (Stockholm, Sweden)

Scandinavian journal of urology

Journal of oncology

BJUI compass

Uppsala Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Uppsala Universitet - May 29o 1998

Sweden

PHD :: Departement of mathemtics

Publications

Gincy George, Hans Garmo, Jan Adolfsson, Kristin Elf, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Johan Styrke, Mieke Van Hemelrijck
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of oncology 2023 (2023)
Gincy George, Hans Garmo, Jan Adolfsson, Kristin Elf, Rolf Gedeborg, Lars Holmberg, Pär Stattin, Johan Styrke, Mieke Van Hemelrijck
Use of Antiepileptic Drugs and Risk of Prostate Cancer: A Nationwide Case-Control Study in Prostate Cancer Data Base Sweden. Journal of oncology 2023 (2023)
Tiago M Bonde, Marcus Westerberg, Markus Aly, Martin Eklund, Jan Adolfsson, Anna Bill-Axelson, Hans Garmo, Pär Stattin, David Robinson
Time to castration-resistant prostate cancer and prostate cancer death according to PSA response in men with non-metastatic prostate cancer treated with gonadotropin releasing hormone agonists. Scandinavian journal of urology 56 (3) (2022)
Rolf Gedeborg, Hans Garmo, Camilla Thellenberg Karlsson, Giuseppe Fallara, Johan Styrke, Ingela Franck Lissbrant, Pär Stattin
Time on treatment with abiraterone in men with de novo metastatic castration sensitive prostate cancer: a drug utilization study. Acta oncologica (Stockholm, Sweden) 61 (3) (2022)
Giuseppe Fallara, Charlotte Alverbratt, Hans Garmo, Hanna Vikman, Marie Hjelm Eriksson, Ingela Franck Lissbrant, Pär Stattin
Time on treatment with abiraterone and enzalutamide in the Patient-overview Prostate Cancer in The National Prostate Cancer Register of Sweden. Acta oncologica (Stockholm, Sweden) 60 (12) (2021)
Gincy George, Hanna Vikman, Rolf Gedeborg, Ingela Franck Lissbrant, Hans Garmo, Johan Styrke, Mieke Van Hemelrijck, Pär Stattin
Risk of cardiovascular events in men on abiraterone or enzalutamide combined with GnRH agonists: nation-wide, population-based cohort study in Sweden. Acta oncologica (Stockholm, Sweden) 60 (4) (2021)
Karl-Johan Lundström, Hans Garmo, Rolf Gedeborg, Pär Stattin, Johan Styrke
Short-term ciprofloxacin prophylaxis for prostate biopsy and risk of aortic aneurysm. Nationwide, population-based cohort study. Scandinavian journal of urology 55 (3) (2021)
Yashar Khoshkar, Marcus Westerberg, Jan Adolfsson, Anna Bill-Axelson, Henrik Olsson, Martin Eklund, Olof Akre, Hans Garmo, Markus Aly
Mortality in men with castration-resistant prostate cancer-A long-term follow-up of a population-based real-world cohort. BJUI compass 3 (2) (2021)
Anna Pia Enblad, Oskar Bergengren, Ove Andrén, Anders Larsson, Katja Fall, Eva Johansson, Hans Garmo, Anna Bill-Axelson
PSA testing patterns in a large Swedish cohort before the implementation of organized PSA testing. Scandinavian journal of urology 54 (5) (2020)
Magdalena Lycken, Linda Drevin, Hans Garmo, Anders Larsson, Ove Andrén, Lars Holmberg, Anna Bill-Axelson
Adherence to guidelines for androgen deprivation therapy after radical prostatectomy: Swedish population-based study. Scandinavian journal of urology 54 (3) (2020)
Kerri Beckmann, Hans Garmo, Per Nilsson, Ingela Franck Lissbrant, Anders Widmark, Pär Stattin
Radical radiotherapy for prostate cancer: patterns of care in Sweden 1998-2016. Acta oncologica (Stockholm, Sweden) 59 (5) (2020)
Marcus Westerberg, Ingela Franck Lissbrant, Jan Erik Damber, David Robinson, Hans Garmo, Pär Stattin
Temporal changes in survival in men with de novo metastatic prostate cancer: nationwide population-based study. Acta oncologica (Stockholm, Sweden) 59 (1) (2019)
Gincy George, Hans Garmo, Sarah Rudman, Lars Holmberg, David Robinson, Pär Stattin, Jan Adolfsson, Mieke Van Hemelrijck
Long-term adherence to GnRH agonists in men with prostate cancer. A nation-wide population-based study in prostate cancer data base Sweden. Scandinavian journal of urology 54 (1) (2019)
Frederik Birkebæk Thomsen, Cecilia Bosco, Hans Garmo, Jan Adolfsson, Niklas Hammar, Pär Stattin, Mieke Van Hemelrijck
Anti-androgen monotherapy versus gonadotropin-releasing hormone agonists in men with advanced, non-metastatic prostate cancer: a register-based, observational study. Acta oncologica (Stockholm, Sweden) 58 (1) (2018)

Hans Garmo.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hans Garmo